Intratumoral heterogeneity as a confounding factor in clonogenic assays for tumour radioresponsiveness

Radiotherapy and Oncology

Volumn 39, Issue 2, 1996, Pages 145-153

  Britten, R A ^a,b   Evans, A J ^a   Allalunis Turner, M J ^a,b   Franko, A J ^a,b   Pearcey, R G ^a,b  

^a CROSS CANCER INSTITUTE   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

cervical cancer; heterogeneity; predictive assays; radiosensitivity

Indexed keywords

ARTICLE; CANCER CELL POPULATION HETEROGENEITY; CLONOGENIC ASSAY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; RADIOSENSITIVITY; UTERINE CERVIX CARCINOMA;

EID: 0029877948     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/0167-8140(96)01719-7     Document Type: Article

References (41)

1. Allalunis-Turner, M.J., Pearcey, R.G., Barron, G.M., Buryn, D.A., Babiak, J.C. and Honoré, L.H. Inherent radiosensitivity testing of tumor biopsies obtained from patients with carcinoma of the cervix or endometrium. Radiother. Oncol. 22: 201-205, 1991.
2. Allalunis-Turner, M.J., Barron, G.M., Day, R.S. III, Dobler, K.D. and Mirzayans, R. Isolation of two cell lines from a human malignant glioma specimen differing in sensitivity to radiation and chemotherapeutic drugs. Radiat. Res. 134: 349-354, 1993.
3. Allam, A., Taghian, A., Gioioso, D., Duffy, M. and Suit, H.D. Intratumoral heterogeneity of malignant gliomas measured in vitro. Int. J. Radiat. Oncol. Biol. Phys. 27: 303-308, 1993.
4. Bonomi, P., Blessing, J.A., Stehman, F.B., DiSaia, P.J., Walton, L. and Major, F.J. Randomized trial of three cisplatin dose schedules in squamous-cell carcinoma of the cervix: A Gynecologic Oncology Group study. J. Clin. Oncol. 3: 1079-1085, 1985.
5. Britten, R.A. and Warenius, H.M. De novo cisplatinum resistance does not influence cellular radiosensitivity. Eur. J. Cancer 29A: 1315-1320, 1993.
6. Britten, R.A., Evans, A.J., Allalunis-Turner, M.J. and Pearcey, R.G. Effect of cisplatin on the clinically relevant radiosensitivity of human cervical carcinoma cell lines. Int. J. Radiat. Oncol. Biol. Phys. 34: 367-374, 1996.
7. Brown, J.M., Evans, J. and Kovacs, M.S. The prediction of human tumor radiosensitivity in situ: an approach using chromosome aberrations detected by fluorescence in situ hybridization. Int. J. Radiat. Oncol. Biol. Phys. 24: 279-286, 1992.
8. Burnet, N.G., Nyman, J., Turesson, I., Wurm, R., Yarnold, J.R. and Peacock, J.H. The relationship between cellular radiation sensitivity and tissue response may provide the basis for individualising radiotherapy schedules. Radiother. Oncol. 33: 228-238, 1994.
9. Burnet, N.G., Nyman, J., Turesson, I., Wurm, R., Yarnold, J.R. and Peacock, J.H. Prediction of normal-tissue tolerance to radiotherapy from in-vitro cellular radiation sensitivity. Lancet 339: 1570-1571, 1992.
10. Coco-Martin, J.M., Smeets, M.F.M.A., Poggensee, M., Mooren, E., Hofland, I., van den Brug, M., Ottenheim, C., Bartelink, H. and Begg, A.C. Use of fluorescence in situ hybridization to measure chromosome aberrations as a predictor of radiosensitivity in human tumour cells. Int. J. Radiat. Biol. 66: 297-307, 1994.
11. Dahlberg, W.K., Little, J.B., Fletcher, J.A., Suit, H.D. and Okunieff P. Radiosensitivity in vitro of human soft tissue sarcoma cell lines and skin fibroblasts derived from the same patients. Int. J. Radiat. Biol. 63: 191-198, 1993.
12. Davidson, S.E., West, C.M.L., Roberts, S.A., Hendry, J.H. and Hunter, R.D. Radiosensitivity testing of primary cervical carcinoma: evaluation of intra-and inter-tumour heterogeneity. Radiother. Oncol. 18: 349-356, 1990.
13. Deacon, J., Peckham, M.J. and Steel, G.G. The radioresponsiveness of human tumours and the initial slope of the cell survival curve. Radiother. Oncol. 2: 317-323, 1984.
14. Fertil, B. and Malaise, E-P. Inherent cellular radiosensitivity as a basic concept for human tumor radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 7: 621-629, 1981.
15. Geara, F.B., Peters, L.J., Ang, K.K., Wike, J.L. and Brock, W.A. Radiosensitivity measurement of keratinocytes and fibroblasts from radiotherapy patients. Int. J. Radiat. Oncol. Biol. Phys. 24: 287-293, 1992.
16. Geara, F.B., Peters, L.J., Ang, K.K., Wike, J.L. and Brock, W.A. Prospective comparison of in vitro normal cell sensitivity and normal tissue reactions in radiotherapy patients. Int. J. Radiat. Oncol. Biol. Phys. 27: 1173-1179, 1993.
17. Girinsky, T., Lubin, R., Pignon, J.P, Chavaudra, N., Gazeau, J., Dubray, B., Cosset, J.M., Socie, G. and Fertil, B. Predictive value of in vitro radiosensitivity parameters in head and neck cancers and cervical carcinomas: preliminary correlations with local control and overall survival. Int. J. Radiat. Oncol. Biol. Phys. 25: 3-7, 1992.
18. Girinsky, T., Bernheim, A., Lubin, R., Tavakoli-Razavi, T., Baker, F., Janot, F., Wibault, P., Cosset, J-M., Duvillard, P., Duverger, A. and Fertil, B. In vitro parameters and treatment outcome in head and neck cancers treated with surgery and/or radiation: cell characterization and correlations with local control and overall survival. Int. J. Radiat. Oncol. Biol. Phys. 30: 789-794, 1994.
19. Johansen, J., Bentzen, S.M., Overgaard, J. and Overgaard, M. Evidence for a positive correlation between in vitro radiosensitivity of normal human skin fibroblasts and the occurrence of subcutaneous fibrosis after radiotherapy. Int. J. Radiat. Biol. 66: 407-412, 1994.
20. Lawton, P.A., Hodgkiss, R.J., Eyden, B.P. and Joiner, M.C. Growth of fibroblasts as a potential confounding factor in soft agar clonogenic assays for tumour cell radiosensitivity. Radiother. Oncol. 32: 218-225, 1994.
21. [21 ] Lee, J.M. and Bernstein, A. p53 mutations increase resistance to ionizing radiation. Proc. Natl. Acad. Sci. USA. 90: 5742-5746, 1993.
22. Leith, J.T., Dexter, D.L., DeWyngaert, J.K., Zeman, E.M., Chu, M.Y., Calabresi, P. and Glicksman, A.S. Differential responses to X-irradiation of subpopulations of two heterogeneous human carcinomas in vitro. Cancer Res. 42: 2556-2561, 1982.
23. Little, C.D., Nau, M.M., Carney, D.N., Gazdar, A.F. and Minna, J.D. Amplification and expression of the c-myc oncogene in human lung cancer cell lines. Nature 306: 194-196, 1983.
24. Parkins, C.S. and Steel, G.G. Growth and radiosensitivity testing of human tumour cells using the adhesive tumour cell culture system. Br. J. Cancer 62: 935-941, 1990.
25. Perez, C.A., Camel, H.M., Kuske, R.R., Kao, M-S., Galakatos, A., Hederman, M.A. and Powers, W.E. Radiation therapy alone in the treatment of carcinoma of the uterine cervix: a 20 year experience. Gynecol. Oncol. 25: 127-140, 1986.
26. Price, P., Bush, C., Parkins, C.S., McMillan, T.J., Robinson, M. and Steel, G.G. Evaluation of cell attachment matrix (CAM) coated plates for primary culture of human tumour biopsies. Radiother. Oncol. 21: 282-285, 1991.
27. Rofstad, E.K., Zaffaroni, N. and Hystad, M.E. Heterogeneous radiation and heat sensitivity in vitro of human melanoma xenograft lines established from different lesions in the same patient. Int. J. Radiat. Biol. 57: 1113-1122, 1990.
28. Sasai, K., Evans, J.W., Kovacs, M.S. and Brown, J.M. Prediction of human cell radiosensitivity: comparison of clonogenic assay with chromosome aberrations scored using premature chromosome condensation with fluorescence in situ hybridization. Int. J. Radiat. Oncol. Biol. Phys. 30: 1127-1132, 1994.
29. Taghian, A., Suit, H., Pardo, F., Gioioso, D., Tomkinson, K., DuBois, W. and Gerweck, L. In vitro intrinsic radiation sensitivity of glioblastoma multiforme. Int. J. Radiat. Oncol. Biol. Phys. 23: 55-62, 1992.
30. Taghian, A., Ramsay, J., Allalunis-Turner, J., Budach, W., Gioioso, D., Pardo, F., Okunieff, P., Bleehen, N., Urtasun, R. and Suit, H. Intrinsic radiation sensitivity may not be the major determinant of the poor clinical outcome of glioblastoma multiforme. Int. J. Radiat. Biol. Phys. 25: 243-249, 1993.
31. Terry, N.H.A., Brock, W.A. and Hendry, J.H. Workshop report: Future directions for predictive assays, 25-27 March 1993, Round Top, Texas. Int. J. Radiat. Biol. 64: 335-338, 1993.
32. Tofilon, P.J., Vines, C.M., Meyn, R.E., Wike, J. and Brock, W.A. Heterogeneity in radiation sensitivity within human primary tumour cell cultures as detected by the SCE assay. Br. J. Cancer 59: 54-60, 1989.
33. Warenius, H.M., Browning, P.G.W., Britten, R.A., Peacock, J.A. and Rapp, U. C-raf-1 proto-oncogene expression relates to radiosensitivity rather than radioresistance. Eur. J. Cancer 30A: 369-375, 1994.
34. Weichselbaum, R.R., Dahlberg, W. and Little, J.B. Inherently radioresistant cells exist in some human tumors. Proc. Natl. Acad. Sci. USA 82: 4732-4735, 1985.
35. Weichselbaum, R.R., Beckett, M.A., Dahlberg, W. and Dritschilo, A. Heterogeneity of radiation response of a parent human epidermoid carcinoma cell line and four clones. Int. J. Radiat. Oncol. Biol. Phys. 14: 907-912, 1988.
36. Weichselbaum, R.R., Beckett, M.A., Vijayakumar, S., Simon, M.A., Awan, A.M., Nachman, J., Panje, W.R., Goldman, M.E., Tybor, A. G., Moran, W.J., Yokes, E.E., Ahmed-Swan, S. and Farhangi, E. Radiobiological characterization of head and neck and sarcoma cells derived from patients prior to radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 19: 313-319, 1990.
37. West, C.M.L., Davidson, S.E. and Hunter, R.D. Evaluation of surviving fraction at 2 Gy as a potential prognostic factor for the radiotherapy of carcinoma of the cervix. Int. J. Radiat. Biol. 56: 761-765, 1989.
38. West, C.M.L., Davidson, S.E., Hendry, J.H. and Hunter, R.D. Prediction of cervical carcinoma response to radiotherapy. Lancet 338: 818, 1991.
39. West, C.M.L. and Hendry, J.H. Intrinsic radiosensitivity as a predictor of patient response to radiotherapy. Br. J. Radiol. Suppl. 24: 146-152, 1992.
40. West, C.M.L., Davidson, S.E., Roberts, S.A. and Hunter, R.D. Intrinsic radiosensitivity and prediction of patient response to radiotherapy for carcinoma of the cervix. Br. J. Cancer 68: 819-823, 1993.
41. Yang, X., Darling, J.L., McMillan, T.J., Peacock, J.H. and Steel, G.G. Heterogeneity of radiosensitivity in a human glioma cell line. Int. J. Radiat. Oncol. Biol. Phys. 22: 103-108, 1991.